Biogen’s stock pops after earnings top estimates and company raises guidance

• Pfizer’s earnings crush estimates as company raises guidance

  Business - MarketWatch - Yesterday

• Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction

  Business - CNBC - 2 hours ago

• Centene’s stock soars 11% after earnings sweep past estimates and company backs guidance

  Business - MarketWatch - 5 days ago

• GM stock has best day since 2020 after automaker tops Wall Street's third-quarter expectations, raises guidance

  Business - CNBC - October 22

• Pfizer tops earnings estimates, hikes full-year guidance as Covid products help sales

  Business - CNBC - 21 hours ago

• AutoNation’s stock falls after earnings fall short of estimates

  Business - MarketWatch - 4 days ago

More from MarketWatch

• Caterpillar’s stock falls as weak equipment sales lead to a rare profit miss

  Business - MarketWatch - 7 minutes ago

• The next recruiter to read your LinkedIn profile could be AI. Here’s what it’s looking for.

  Business - MarketWatch - 8 minutes ago

• U.K. government bond yields volatile as budget delivers £40 billion tax hike

  Business - MarketWatch - 22 minutes ago

• Super Micro’s troubles build as auditor resigns, sending stock tumbling 30%

  Business - MarketWatch - 42 minutes ago

• Eli Lilly’s stock dives as Mounjaro and Zepbound sales miss, but Citi says buy

  Business - MarketWatch - 53 minutes ago